Data Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different Laboratories

Immune checkpoint inhibitors, which unleash a patient’s own T cells to kill tumors, are revolutionizing cancer treatment. Several independent studies suggest that higher non-synonymous mutational burden assessed by whole exome sequencing (WES) in tumors is associated with improved objective response...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Qiu, Ping, Pang, Ling, Arreaza, Gladys, Maguire, Maureen, Chang, Ken C. N., Marton, Matthew J., Levitan, Diane
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2016
Assuntos:
Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881477/
https://ncbi.nlm.nih.gov/pubmed/27136543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17050651
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares